Advertisement
Screener

4D Molecular Therapeutics, Inc. (FDMT) ROA

4D Molecular Therapeutics, Inc. (FDMT) ROA

  • 2026-06-30: ROA -36.37%.
  • 2026-03-31: ROA -31.37%.
  • 2025-12-31: ROA -24.72%.
  • 2025-09-30: ROA -49.34%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-36.37%
2026-03-31-31.37%
2025-12-31-24.72%
2025-09-30-49.34%
2025-06-30-41.41%
2025-03-31-34.21%
2024-12-31-28.71%
2024-09-30-23.75%
2024-06-30-17.72%
2024-03-31-16.60%
2023-12-31-29.67%
2023-09-30-26.53%
2023-06-30-31.59%
2023-03-31-45.01%
2022-12-31-41.05%
2022-09-30-37.55%
2022-06-30-33.59%
2022-03-31-25.01%
2021-12-31-20.18%
2021-09-30-27.75%
2021-06-30-20.54%
2021-03-31-22.19%
2020-12-31-19.66%

Annual ROA

DateROA
2025-12-31-24.72%
2024-12-31-28.71%
2023-12-31-29.67%
2022-12-31-41.05%
2021-12-31-20.18%
2020-12-31-19.66%
2019-12-31-84.67%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
Entera Bio Ltd. (ENTX)$0.485B